AEON Biopharma (AEON) Current Leases (2022 - 2024)
AEON Biopharma (AEON) posted Current Leases of $121000.0 for Q4 2024, down 56.47% sequentially from $278000.0 in Q4 2023, and down 56.47% YoY from $278000.0 in Q1 2024.
AEON Biopharma (AEON) Current Leases (2022 - 2024) Analysis & Trends
AEON Biopharma has reported Current Leases for 3 years, with the latest figure at $121000.0 in Q4 2024.
- Quarterly Current Leases fell 56.47% year-over-year to $121000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $121000.0 (down 56.47% YoY) and the FY2024 annual result came in at $121000.0, down 56.47% from the prior year.
- Current Leases fell to $121000.0 in Q4 2024 per AEON's latest filing, from $278000.0 in the prior quarter.
- Over five years, Current Leases peaked at $278000.0 in Q4 2023 and troughed at $121000.0 in Q4 2024.
- A 3-year average of $218666.7 and a median of $257000.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases gained 8.17% in 2023, then tumbled 56.47% in 2024.
- Over 3 years, Current Leases stood at $257000.0 in 2022, then increased by 8.17% to $278000.0 in 2023, then sank by 56.47% to $121000.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $121000.0, $278000.0, and $257000.0 for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | - |
| 10 | AEON Biopharma | 9.88 Mn | 6.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 121,000.00 |
| Dec 31, 2023 | 278,000.00 |
| Dec 31, 2022 | 257,000.00 |